Evidence map›Paper›PMID 35244317›Full record

ReviewBipolar disorders2022

Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder.

Melvin G McInnis, Ole A Andreassen, Ana C Andreazza, Uri Alon, Michael Berk, Teri Brister, Katherine E Burdick, Donghong Cui, Mark Frye, Marion Leboyer and 8 more

Abstract readReview
In one paragraph

Review in Bipolar disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Addressing the unmet needs of bipolar disorder in Australia and beyond.The Australian and New Zealand journal of psychiatry · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biomarkers in psychiatric disorders: status quo, impediments and facilitators.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  11. Biomarkers for clinical use in psychiatry: where are we and will we ever get there?World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Melvin G McInnisDepartment of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-0375-6247
Ole A AndreassenNORMENT Centre, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-4461-3568
Ana C AndreazzaDepartment of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-4323-7273
Uri AlonWeizmann Institute, Rehovot, Israel.ORCID 0000-0001-5796-9988
Michael BerkDeakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.ORCID 0000-0002-5554-6946
Teri BristerNational Alliance on Mental Illness, Arlington, Virginia, USA.ORCID 0000-0002-6200-6892
Katherine E BurdickBrigham Womens Hospital, Harvard University, Boston, Massachusetts, USA.ORCID 0000-0003-4417-4988
Donghong CuiShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai Mental Health Center, Shangai, China.ORCID 0000-0001-6941-0997
Mark FryeMayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6997-4215
Marion LeboyerDépartement de psychiatrie, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires H. Mondor, DMU IMPACT, INSERM, translational Neuropsychiatry, Fondation FondaMental, Creteil, France.ORCID 0000-0001-5473-3697
Philip B MitchellUniversity of New South Wales, Sydney, Australia.ORCID 0000-0002-7954-5235
Kathleen MerikangasIntramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA.ORCID 0000-0002-4667-2414
Andrew A NierenbergMass General Hospital, Harvard University, Boston, Massachusetts, USA.ORCID 0000-0003-2897-0458
John I NurnbergerIndiana University, Indianapolis, Indiana, USA.ORCID 0000-0002-7674-1767
Daniel PhamMilken Institute, Center for Strategic Philanthopy, Washington, District of Columbia, USA.ORCID 0000-0003-2734-0657
Eduard VietaBipolar and Depressive disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.ORCID 0000-0002-0548-0053
Lakshmi N YathamUniversity of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-7405-0954
Allan H YoungDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London & South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, Kent, UK.ORCID 0000-0003-2291-6952

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Family Study of Affective and Anxiety Spectrum DisordersZIAMH002804 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MERIKANGAS, KATHLEEN R · 2009 to 2025
$37.5M
Brain-based Mechanisms of Emotion Regulation in Aging and Mood DisordersR01MH124381 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BURDICK, KATHERINE ELIZABETH, GUNNING, FAITH M · 2021 to 2025
$4.1M
Longitudinal Voice Patterns in Bipolar DisorderR34MH100404 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCINNIS, MELVIN G · 2013 to 2015
$700k
MHealth Monitoring of Acoustic and Behavioral Patterns in Bipolar Disorder Across CulturesR21MH114835 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCINNIS, MELVIN G · 2017 to 2018
$332k
NCATS NIH HHS UL1 TR002240NIMH NIH HHS R01 MH124381NIMH NIH HHS R21 MH114835NIMH NIH HHS R34 MH100404
6 · The paper itself

Abstract

Bipolar disorder (BD) is a complex and dynamic condition with a typical onset in late adolescence or early adulthood followed by an episodic course with intervening periods of subthreshold symptoms or euthymia. It is complicated by the accumulation of comorbid medical and psychiatric disorders. The etiology of BD remains unknown and no reliable biological markers have yet been identified. This is likely due to lack of comprehensive ontological framework and, most importantly, the fact that most studies have been based on small nonrepresentative clinical samples with cross-sectional designs. We propose to establish large, global longitudinal cohorts of BD studied consistently in a multidimensional and multidisciplinary manner to determine etiology and help improve treatment. Herein we propose collection of a broad range of data that reflect the heterogenic phenotypic manifestations of BD that include dimensional and categorical measures of mood, neurocognitive, personality, behavior, sleep and circadian, life-story, and outcomes domains. In combination with genetic and biological information such an approach promotes the integrating and harmonizing of data within and across current ontology systems while supporting a paradigm shift that will facilitate discovery and become the basis for novel hypotheses.

Indexed as

Bipolar DisorderAdolescentAdultComorbidityCross-Sectional StudiesHumansLongitudinal StudiesPersonalitybehaviorcircadianontologyoutcomespersonalitypsychology

Identifiers

PMID35244317
PMCPMC9440950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.